MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bonhaus, D. W.
Right arrow Articles by McNamara, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bonhaus, D. W.
Right arrow Articles by McNamara, J. O.

Glycine regulation of the N-methyl-D-aspartate receptor-gated ion channel in hippocampal membranes

DW Bonhaus, GC Yeh, L Skaryak and JO McNamara

Department of Medicine (Neurology), Duke University Medical Center, Durham, North Carolina.

The N-methyl-D-aspartate receptor-gated ion channel (NMDA channel) is regulated by glycine. To examine the interaction of glycine and NMDA receptor ligands on NMDA channel function, we used a biochemical marker of channel opening, [3H]N-(1-[thienyl]cyclohexyl)piperidine (TCP). We quantified [3H]glycine,L-[3H]glutamate, and TCP binding in an identical membrane preparation. This allowed direct comparison of NMDA and glycine receptor occupancy and channel activation. Glycine increased the association and dissociation rates of NMDA-dependent TCP binding to hippocampal membranes, without altering the Kd or Bmax for TCP binding. Structurally similar amino acids mimicked the action of glycine, with D- isomers being more potent than L-isomers. The potency of glycine in regulating TCP binding matched that for displacing [3H]glycine. Glycine stimulation of TCP binding required the presence of NMDA agonists and was inhibited by the NMDA antagonist D-2-amino-5-phosphonovaleric acid. Glycine stimulation of NMDA-dependent TCP binding was not associated with an increase in agonist binding to the NMDA receptor. Likewise, NMDA stimulation of glycine-dependent TCP binding was not associated with an increase in the binding of glycine to the glycine receptor. These findings permit the following conclusions: 1) glycine stimulates TCP binding solely by increasing the access of TCP to its site in the NMDA channel; 2) TCP binding can be used to quantify glycine regulation of the NMDA channel; 3) a stereospecific glycine receptor, as part of the NMDA receptor-channel complex, regulates NMDA-evoked channel opening by a mechanism not involving increased agonist binding to the NMDA receptor. Thus, it appears that the mechanism of glycine and NMDA receptor regulation of the NMDA channel is analogous to that of a two- key lock; both receptors, by independent and mutually required mechanisms, alter channel conformation to allow ion passage.

Volume 36, Issue 2, pp. 273-279, 08/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G.-C. Yeh, J.-C. Chen, H.-C. Tsai, H.-H. Wu, C.-Y. Lin, P.-C. Hsu, and Y.-C. Peng
Amphetamine Inhibits the N-Methyl-D-Aspartate Receptor-Mediated Responses by Directly Interacting with The Receptor/Channel Complex
J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 1008 - 1016.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. N. Nagendra, M. D. Faiman, K. Davis, J.-Y. Wu, X. Newby, and J. V. Schloss
Carbamoylation of Brain Glutamate Receptors by a Disulfiram Metabolite
J. Biol. Chem., September 26, 1997; 272(39): 24247 - 24251.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1989 by the American Society for Pharmacology and Experimental Therapeutics